Work

Zongertinib (Hernexeos) for NSCLC

Year: 2025

Type: article

Source: The medical letter on drugs and therapeutics/The medical letter

DOI: 10.58347/tml.2025.1738d

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4414422350

FWCI:

Cites:

Cited by:

Related to: